Asian Science Citation Index - Articles written by A. T. Hattersley

Articles by A. T. Hattersley (9)

Stability and Reproducibility of a Single-Sample Urinary C-Peptide/Creatinine Ratio and Its Correlation with 24-h Urinary C-Peptide

T. J McDonald, B. A Knight, B. M Shields, P Bowman, M. B Salzmann and A. T. Hattersley

Clinical Chemistry 55 ( 11 ): 2035 - 2039 , 2009

Type 2 Diabetes Risk Alleles Are Associated With Reduced Size at Birth

R. M Freathy, A. J Bennett, S. M Ring, B Shields, C. J Groves, N. J Timpson, M. N Weedon, E Zeggini, C. M Lindgren, H Lango, J. R.B Perry, A Pouta, A Ruokonen, E Hypponen, C Power, P Elliott, D. P Strachan, M. R Jarvelin, G. D Smith, M. I McCarthy, T. M Frayling and A. T. Hattersley

Diabetes 58 ( 6 ): 1428 - 1433 , 2009

Reduced peripheral blood mitochondrial DNA content is not a risk factor for Type 2 diabetes

R. Singh, A. T. Hattersley and L. W. Harries

Diabetic Medicine 24 ( 7 ): 784 - 787 , 2007

Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes

O. Rubio-Cabezas, E. L. Edghill, J. Argente and A. T. Hattersley

Diabetic Medicine 26 ( 10 ): 1070 - 1074 , 2009

Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV)

J. Grulich-Henn, V. Wagner, A. Thon, E. Schober, W. Marg, T. M. Kapellen, H. Haberland, K. Raile, S. Ellard, S. E. Flanagan, A. T. Hattersley and R. W. Holl

Diabetic Medicine 27 ( 6 ): 709 - 712 , 2010

Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene

A. M. Steele, B. M. Shields, M. Shepherd, S. Ellard, A. T. Hattersley and E. R. Pearson

Diabetic Medicine 27 ( 2 ): 157 - 161 , 2010

Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes

T. J. McDonald, K. Colclough, R. Brown, B. Shields, M. Shepherd, P. Bingley, A. Williams, A. T. Hattersley and Sian Ellard

Diabetic Medicine 28 ( 9 ): 1028 - 1033 , 2011

Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes

A. G. Jones, R. E. J. Besser, T. J. McDonald, B. M. Shields, S. V. Hope, P. Bowman, R. A. Oram, B. A. Knight and A. T. Hattersley

Diabetic Medicine 28 ( 9 ): 1034 - 1038 , 2011

Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes

P. Bowman, T. J. McDonald, B. M. Shields, B. A. Knight and A. T. Hattersley

Diabetic Medicine 29 ( 1 ): 90 - 93 , 2012